表紙
市場調查報告書

酒精性肝炎治療藥的全球市場:產業分析,市場規模、佔有率、成長率、趨勢、預測 (2020∼2030年)

Alcoholic Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

出版商 Transparency Market Research 商品編碼 953567
出版日期 內容資訊 英文 173 Pages
商品交期: 最快1-2個工作天內
價格
酒精性肝炎治療藥的全球市場:產業分析,市場規模、佔有率、成長率、趨勢、預測 (2020∼2030年) Alcoholic Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
出版日期: 2020年06月17日內容資訊: 英文 173 Pages
簡介

本報告提供全球酒精性肝炎的治療藥的市場相關分析,市場基本結構和主要的影響要素,市場規模趨勢預測 (過去2年、今後11年份),各治療法、各用途、各流通管道及各地區詳細趨勢,競爭環境 (市場佔有率結構),主要企業簡介等調查。

目錄

第1章 序文

第2章 前提條件與調查方法

第3章 摘要整理

第4章 市場概要

  • 產品概要
  • 市場動態
  • 推動及阻礙市場要素分析 (概要)
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 全球酒精性肝炎治療藥市場:市場收益額的預測
  • 全球酒精性肝炎治療藥市場未來展望

第5章 市場未來展望

  • 新型冠狀病毒感染疾病 (COVID-19) 感染擴大對全球酒精性肝炎治療藥產業的影響
  • 法規方案:各地區/全球
  • 醫療概要
  • 開發平台分析
  • 酒精性肝疾病的流行病學
  • 酒精性肝炎概要

第6章 全球酒精性肝炎治療藥市場分析:各治療藥物

  • 簡介
  • 市場收益額佔有率與市場向心力分析:各治療藥物
  • 市場規模與其預測:各治療藥物
    • 皮質類固醇
    • 血液流變學劑
    • 合成代謝類固醇
    • 其他
  • 市場分析:各治療藥物

第7章 全球酒精性肝炎治療藥市場分析:各用途

  • 簡介
  • 市場收益額佔有率與市場向心力分析:各用途
  • 市場規模與其預測:各用途
    • 輕度
    • 重度/慢性
  • 市場分析:各用途

第8章 全球酒精性肝炎治療藥市場分析:各流通管道

  • 簡介
  • 市場收益額佔有率與市場向心力分析:各流通管道
  • 市場規模與其預測:各流通管道
    • 醫院藥局
    • 零售藥局
    • 線上藥局
  • 市場分析:各銷售管道

第8章 全球酒精性肝炎治療藥市場分析:各地區

  • 簡介
  • 市場收益額佔有率與市場向心力分析:各地區
  • 市場規模與其預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲

第10章 北美的酒精性肝炎治療藥市場分析

  • 北美的酒精性肝炎治療藥市場分析
  • 市場收益額佔有率與市場向心力分析:各治療藥物
  • 市場預測:各治療藥物
  • 市場收益額佔有率與市場向心力分析:各用途
  • 市場預測:各用途
  • 市場收益額佔有率與市場向心力分析:各流通管道
  • 市場預測:各流通管道
  • 市場收益額佔有率與市場向心力分析:各國
  • 市場預測:各國
    • 美國
    • 加拿大

第11章 歐洲的酒精性肝炎治療藥市場分析

第12章 亞太地區的酒精性肝炎治療藥市場分析

第13章 南美的酒精性肝炎治療藥市場分析

第14章 中東、非洲的酒精性肝炎治療藥市場分析

第15章 競爭情形

  • 企業簡介
    • Gilead Sciences, Inc.
    • Sanofi
    • Generon Pharmaceutical Technology (Shanghai) Co., Ltd.
    • Immuron Ltd.
    • Intercept Pharmaceuticals, Inc.
目錄
Product Code: TMRGL12209

Title:
Alcoholic Hepatitis Therapeutics Market (Treatment: Corticosteroids, Hemorrheologic Agents, Anabolic Steroids, and Others; Application: Mild and Severe/Chronic; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030.

Scope of the Report

TMR's report on the global alcoholic hepatitis therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global alcoholic hepatitis therapeutics market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global alcoholic hepatitis therapeutics market from 2020 to 2030.

The report is prepared after an extensive research. Primary research involves bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players' product literature, annual reports, press releases, and relevant documents to understand the alcoholic hepatitis therapeutics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the alcoholic hepatitis therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global alcoholic hepatitis therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global alcoholic hepatitis therapeutics market.

The report delves into the competition landscape of the global alcoholic hepatitis therapeutics market. Key players operating in the global alcoholic hepatitis therapeutics market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global alcoholic hepatitis therapeutics market profiled in this report.

Key Questions Answered:

  • What is the sales/revenue generated by alcoholic hepatitis therapeutics across all regions during the forecast period?
  • What are the opportunities in the global alcoholic hepatitis therapeutics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which treatment segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global alcoholic hepatitis therapeutics market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global alcoholic hepatitis therapeutics market in terms of treatment, application, distribution channel, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global alcoholic hepatitis therapeutics market.

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Alcoholic Hepatitis Therapeutics Market Snapshot

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Market Dynamics
  • 4.3. Drivers and Restraints Snapshot Analysis
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
    • 4.3.4. Key Trends
  • 4.4. Global Alcoholic Hepatitis Therapeutics Market Revenue Projection
  • 4.5. Global Alcoholic Hepatitis Therapeutics Market Outlook

5. Market Outlook

  • 5.1. COVID-19 Pandemic Impact on Global Alcoholic Hepatitis Therapeutics Industry
  • 5.2. Regulatory Scenario, by Region/globally
  • 5.3. Health Care Overview
  • 5.4. Pipeline Analysis
  • 5.5. Epidemiology of Alcoholic Liver Diseases
  • 5.6. Overview of Alcoholic Hepatitis

6. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment

  • 6.1. Introduction
  • 6.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 6.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 6.3.1. Corticosteroids
    • 6.3.2. Hemorrheologic Agents
    • 6.3.3. Anabolic Steroids
    • 6.3.4. Others
  • 6.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment

7. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application

  • 7.1. Introduction
  • 7.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 7.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 7.3.1. Mild
    • 7.3.2. Severe/Chronic
  • 7.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application

8. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 8.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel

9. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Region

  • 9.1. Global Alcoholic Hepatitis Therapeutics Market Scenario, by Country
  • 9.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Region
  • 9.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa

10. North America Alcoholic Hepatitis Therapeutics Market Analysis

  • 10.1. North America Alcoholic Hepatitis Therapeutics Market Analysis
  • 10.2. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 10.3. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 10.3.1. Corticosteroids
    • 10.3.2. Hemorrheologic Agents
    • 10.3.3. Anabolic Steroids
    • 10.3.4. Others
  • 10.4. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 10.5. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 10.5.1. Mild
    • 10.5.2. Severe/Chronic
  • 10.6. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 10.7. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 10.7.1. Hospital Pharmacies
    • 10.7.2. Retail Pharmacies
    • 10.7.3. Online Pharmacies
  • 10.8. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country
  • 10.9. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Country
    • 10.9.1. U.S.
    • 10.9.2. Canada

11. Europe Alcoholic Hepatitis Therapeutics Market Analysis

  • 11.1. Europe Alcoholic Hepatitis Therapeutics Market Analysis
  • 11.2. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 11.3. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 11.3.1. Corticosteroids
    • 11.3.2. Hemorrheologic Agents
    • 11.3.3. Anabolic Steroids
    • 11.3.4. Others
  • 11.4. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 11.5. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 11.5.1. Mild
    • 11.5.2. Severe/Chronic
  • 11.6. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 11.7. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 11.7.1. Hospital Pharmacies
    • 11.7.2. Retail Pharmacies
    • 11.7.3. Online Pharmacies
  • 11.8. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 11.9. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
    • 11.9.1. U.K.
    • 11.9.2. Germany
    • 11.9.3. France
    • 11.9.4. Spain
    • 11.9.5. Italy
    • 11.9.6. Rest of Europe

12. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis

  • 12.1. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis
  • 12.2. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 12.3. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 12.3.1. Corticosteroids
    • 12.3.2. Hemorrheologic Agents
    • 12.3.3. Anabolic Steroids
    • 12.3.4. Others
  • 12.4. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 12.5. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 12.5.1. Mild
    • 12.5.2. Severe/Chronic
  • 12.6. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 12.7. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 12.7.1. Hospital Pharmacies
    • 12.7.2. Retail Pharmacies
    • 12.7.3. Online Pharmacies
  • 12.8. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 12.9. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
    • 12.9.1. Australia & New Zealand
    • 12.9.2. Japan
    • 12.9.3. China
    • 12.9.4. India
    • 12.9.5. Rest of Asia Pacific

13. Latin America Alcoholic Hepatitis Therapeutics Market Analysis

  • 13.1. Latin America Alcoholic Hepatitis Therapeutics Market Analysis
  • 13.2. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 13.3. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 13.3.1. Corticosteroids
    • 13.3.2. Hemorrheologic Agents
    • 13.3.3. Anabolic Steroids
    • 13.3.4. Others
  • 13.4. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 13.5. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 13.5.1. Mild
    • 13.5.2. Severe/Chronic
  • 13.6. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 13.7. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 13.7.1. Hospital Pharmacies
    • 13.7.2. Retail Pharmacies
    • 13.7.3. Online Pharmacies
  • 13.8. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 13.9. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
    • 13.9.1. Brazil
    • 13.9.2. Mexico
    • 13.9.3. Rest of Latin America

14. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis

  • 14.1. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis
  • 14.2. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 14.3. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 14.3.1. Corticosteroids
    • 14.3.2. Hemorrheologic Agents
    • 14.3.3. Anabolic Steroids
    • 14.3.4. Others
  • 14.4. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 14.5. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 14.5.1. Mild
    • 14.5.2. Severe/Chronic
  • 14.6. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 14.7. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 14.7.1. Hospital Pharmacies
    • 14.7.2. Retail Pharmacies
    • 14.7.3. Online Pharmacies
  • 14.8. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 14.9. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
    • 14.9.1. GCC Countries
    • 14.9.2. South Africa
    • 14.9.3. Rest of Middle East & Africa

15. Competitive Landscape

  • 15.1. Company Profile
    • 15.1.1. Gilead Sciences, Inc.
      • 15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.1.2. Financial Overview
      • 15.1.1.3. Product Portfolio
      • 15.1.1.4. SWOT Analysis
      • 15.1.1.5. Strategic Overview
    • 15.1.2. Sanofi
      • 15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.2.2. Financial Overview
      • 15.1.2.3. Product Portfolio
      • 15.1.2.4. SWOT Analysis
      • 15.1.2.5. Strategic Overview
    • 15.1.3. Generon Pharmaceutical Technology (Shanghai) Co., Ltd.
      • 15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.3.2. Financial Overview
      • 15.1.3.3. Product Portfolio
      • 15.1.3.4. SWOT Analysis
      • 15.1.3.5. Strategic Overview
    • 15.1.4. Immuron Ltd.
      • 15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.4.2. Product Portfolio
      • 15.1.4.3. SWOT Analysis
      • 15.1.4.4. Strategic Overview
    • 15.1.5. Intercept Pharmaceuticals, Inc.
      • 15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.5.2. Financial Overview
      • 15.1.5.3. Product Portfolio
      • 15.1.5.4. SWOT Analysis
      • 15.1.5.5. Strategic Overview

List of Tables

  • Table 01: Alcohol, total per capita (15+) consumption (in liters of pure alcohol) with 95%CI, by Country, 2016
  • Table 02: Epidemiology of Covid-19 Country/Sub-region
  • Table 03: Gross Domestic Product (GDP), by Country, 2014-2017
  • Table 04: Pipeline Analysis of Alcoholic Hepatitis Therapeutics
  • Table 05: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 06: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 07: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 08: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 09: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 10: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Application, 2018-2030
  • Table 11: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 12: North America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 13: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 14: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Application, 2018-2030
  • Table 15: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 16: Europe Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 17: Asia Pacific Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 18: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 19: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 20: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 21: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 22: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 23: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 24: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 25: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 26: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 27: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 28: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030

List of Figures

  • Figure 01: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2019 and 2030
  • Figure 02: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 03: Market Value Share, by Treatment, 2019
  • Figure 04: Market Value Share, by Application, 2019
  • Figure 05: Market Value Share, by Distribution Channel, 2019
  • Figure 06: Market Value Share, by Region, 2019
  • Figure 07: Regulatory Approval Process - U.S.
  • Figure 08: Regulatory Approval Process - Europe
  • Figure 09: Regulatory Approval Process - Japan
  • Figure 10: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 11: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020-2030
  • Figure 12: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2018-2030
  • Figure 13: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrheologic Agents, 2018-2030
  • Figure 14: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anabolic Steroids, 2018-2030
  • Figure 15: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2030
  • Figure 16: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 17: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 18: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Mild AH, 2018-2030
  • Figure 19: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Severe/Chronic AH, 2018-2030
  • Figure 20: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 21: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 22: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2030
  • Figure 23: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018-2030
  • Figure 24: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018-2030
  • Figure 25: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 26: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Region, 2020¬¬-2030
  • Figure 27: North America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 28: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬-2030
  • Figure 29: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 30: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 31: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 32: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 33: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 34: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 35: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 36: Europe Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 37: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬--2030
  • Figure 38: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 39: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 40: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 41: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 42: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 43: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 44: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 45: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 46: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬-2030
  • Figure 47: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 48: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 49: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 50: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 51: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 52: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 53: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 54: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 55: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬-2030
  • Figure 56: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 57: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 58: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 59: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 60: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 61: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 62: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 63 Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 64: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬-2030
  • Figure 65: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 66: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 67: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 68: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 69: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 70: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 71: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 72: Gilead Sciences, Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2016-2019
  • Figure 73: Gilead Sciences, Inc., Breakdown of Net Sales, by Region, 2019
  • Figure 74: Gilead Sciences, Inc., R&D Intensity (%) - Company Level or Segment Level, 2016-2019
  • Figure 75: Sanofi, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 76: Sanofi, Breakdown of Net Sales, by Business Segment, 2019
  • Figure 77: Sanofi, Breakdown of Net Sales, by Region, 2019
  • Figure 78: Immuron, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 79: Immuron, R&D Expenses - Company Level, 2016-2019
  • Figure 80: Intercept Pharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 81: Intercept Pharmaceuticals, Inc., R&D Expenses - Company Level, 2016-2019